EcoR1 Capital to Engage with Galapagos (GLPG) on Company Performance and Governance

Aug 24, 2024

∙ Paid

Key Summary: On August 23, 2024, EcoR1 Capital (9.9%) announced plans to discuss company performance, operations, strategic opportunities, and governance, including Board composition, with management and the board.

Market Cap: $1.7 billion | GALAPAGOS NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the Uni…

This post is for paid subscribers

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts

Snowball Research

EcoR1 Capital to Engage with Galapagos (GLPG) on Company Performance and Governance

This post is for paid subscribers